. (NVUS)

- - (-)

Market Cap: -

As of 12/31/69 07:00 PM EST. Market closed.

(NVUS)

. (NVUS)

-
- (-)

Market Cap: -

As of 12/31/69 07:00 PM EST. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Perrin StevenPresidentNov 23, 2022 Buy$2.601,0002,5971,000Nov 23, 2022, 04:05 PM
Gros David-Alexandre CChief Executive OfficerDec 20, 2021 Buy$4.482,0008,9609,000Dec 21, 2021, 04:05 PM
Gros David-Alexandre CChief Executive OfficerAug 17, 2021 Buy$6.214,00024,8407,000Aug 19, 2021, 04:05 PM
Gros David-Alexandre CChief Executive OfficerJun 09, 2021 Buy$8.013,00024,0303,000Jun 10, 2021, 05:25 PM
OrbiMed Israel GP Ltd.10% OwnerDec 02, 2020 Sale$21.60103,2002,229,12073,650Dec 04, 2020, 05:17 PM
Logos Global Management LP10% OwnerOct 30, 2020 Buy$25.4492,0402,341,714224,071Nov 06, 2020, 06:46 PM
Logos Global Management LP10% OwnerOct 30, 2020 Sale$26.6412,969345,559199,973Nov 06, 2020, 06:46 PM
TURKEL CATHERINE C.PresidentMay 21, 2019 Sale$1.911,9143,65888,662May 22, 2019, 04:12 PM
TURKEL CATHERINE C.PresidentMay 20, 2019 Sale$1.967,62314,95390,576May 22, 2019, 04:12 PM
Kuwahara JonSee RemarksMay 21, 2019 Sale$1.911,0582,0225,974May 22, 2019, 04:02 PM
Kuwahara JonSee RemarksMay 20, 2019 Sale$1.964,2188,2747,032May 22, 2019, 04:02 PM
FLESHER GREGORY J.Chief Executive OfficerMay 21, 2019 Sale$1.912,9375,614156,918May 22, 2019, 04:01 PM
FLESHER GREGORY J.Chief Executive OfficerMay 20, 2019 Sale$1.9611,70122,953159,855May 22, 2019, 04:01 PM
OrbiMed Israel GP Ltd.DirectorMay 02, 2019 Buy$3.10646,2042,003,2323,183,314May 06, 2019, 05:30 PM
Chimovits ErezDirectorMay 02, 2019 Buy$3.10646,2042,003,2323,183,314May 06, 2019, 05:28 PM
LIFESCI INDEX PARTNERS LLC10% OwnerApr 30, 2019 Sale$2.702005401,065,867May 02, 2019, 04:47 PM
TURKEL CATHERINE C.PresidentSep 11, 2018 Buy$4.5617,04877,67161,567Sep 13, 2018, 08:00 PM
TURKEL CATHERINE C.PresidentSep 12, 2018 Buy$5.0216,63283,47678,199Sep 13, 2018, 08:00 PM
TURKEL CATHERINE C.PresidentSep 05, 2018 Buy$3.978053,193805Sep 07, 2018, 08:00 PM
FLESHER GREGORY J.Chief Executive OfficerMay 10, 2017 Buy$9.9958,959589,000115,856May 11, 2017, 08:36 PM
TURKEL CATHERINE C.Chief Development OfficerMay 10, 2017 Buy$9.9911,111110,99924,519May 11, 2017, 08:33 PM
OCAMPO CHRISTINESee RemarksMay 10, 2017 Buy$9.9910,010100,00021,590May 11, 2017, 08:30 PM
Buckley Stephen Jr.DirectorMar 15, 2016 Buy$5.748,00045,92011,000Mar 15, 2016, 04:02 PM
Morrison Jodie PopePresident and CEOJan 08, 2016 Option Exercise$1.1628,01532,44957,566Jan 08, 2016, 04:01 PM
Buckley Stephen Jr.DirectorNov 11, 2015 Buy$11.253,00033,7503,000Nov 12, 2015, 09:06 AM
McBride John S.Chief Operating OfficerSep 21, 2015 Option Exercise$4.1913,50056,56513,500Sep 22, 2015, 04:31 PM
McBride John S.Chief Operating OfficerSep 21, 2015 Sale$14.0113,500189,1350Sep 22, 2015, 04:31 PM
Kalowski LeeChief Financial OfficerSep 08, 2015 Sale$13.134,66861,29140,953Sep 08, 2015, 04:23 PM
Kalowski LeeChief Financial OfficerSep 02, 2015 Sale$12.962,15827,96845,621Sep 04, 2015, 04:03 PM
Morrison Jodie PopePresident and CEOJul 29, 2015 Option Exercise$0.8910,5649,41129,551Jul 30, 2015, 05:33 PM
Morrison Jodie PopePresident and CEOJul 28, 2015 Option Exercise$1.5812,00018,96031,551Jul 30, 2015, 05:33 PM
Morrison Jodie PopePresident and CEOJul 29, 2015 Sale$13.705647,72719,551Jul 30, 2015, 05:33 PM
Morrison Jodie PopePresident and CEOJul 28, 2015 Sale$13.7012,000164,40019,551Jul 30, 2015, 05:33 PM
Morrison Jodie PopeJul 22, 2015 Option Exercise$1.0610,00010,62419,551Jul 24, 2015, 04:23 PM
Novartis Bioventures Ltd10% OwnerJul 15, 2015 Sale$14.263,56650,8444,493,458Jul 17, 2015, 04:05 PM
Novartis Bioventures Ltd10% OwnerJul 14, 2015 Sale$14.4127,861401,4774,497,024Jul 15, 2015, 04:18 PM
Novartis Bioventures Ltd10% OwnerJul 13, 2015 Sale$14.2020,611292,7174,524,885Jul 15, 2015, 04:18 PM
Morrison Jodie PopePresident and CEOJun 29, 2015 Option Exercise$1.588,00012,64017,551Jun 30, 2015, 04:48 PM
Morrison Jodie PopePresident and CEOJun 26, 2015 Option Exercise$1.588,00012,64017,551Jun 30, 2015, 04:48 PM
Morrison Jodie PopePresident and CEOJun 29, 2015 Sale$13.708,000109,6009,551Jun 30, 2015, 04:48 PM
Morrison Jodie PopePresident and CEOJun 26, 2015 Sale$13.838,000110,6409,551Jun 30, 2015, 04:48 PM
McBride John S.Chief Operating OfficerJun 24, 2015 Option Exercise$4.193001,257300Jun 24, 2015, 04:27 PM
McBride John S.Chief Operating OfficerJun 23, 2015 Option Exercise$4.196,70028,0736,700Jun 24, 2015, 04:27 PM
McBride John S.Chief Operating OfficerJun 22, 2015 Option Exercise$4.192,0008,3802,000Jun 24, 2015, 04:27 PM
McBride John S.Chief Operating OfficerJun 23, 2015 Sale$14.006,70093,8000Jun 24, 2015, 04:27 PM
McBride John S.Chief Operating OfficerJun 22, 2015 Sale$14.022,00028,0400Jun 24, 2015, 04:27 PM
McBride John S.Chief Operating OfficerJun 24, 2015 Sale$14.203004,2600Jun 24, 2015, 04:27 PM
Novartis Bioventures Ltd10% OwnerJun 16, 2015 Sale$14.271,12015,9824,545,496Jun 18, 2015, 12:54 PM
Novartis Bioventures Ltd10% OwnerJun 15, 2014 Sale$14.2014,777209,8334,546,616Jun 16, 2015, 04:17 PM
Novartis Bioventures Ltd10% OwnerJun 12, 2015 Sale$14.205,91984,0504,561,393Jun 16, 2015, 04:17 PM
Novartis Bioventures Ltd10% OwnerJun 11, 2015 Sale$14.2027,875395,8254,567,312Jun 12, 2015, 04:05 PM
Kalowski LeeChief Financial OfficerApr 16, 2015 Sale$13.004,56759,37147,779Apr 20, 2015, 05:08 PM
Kalowski LeeChief Financial OfficerApr 02, 2015 Sale$11.452,25825,85452,346Apr 06, 2015, 05:23 PM
Novartis Bioventures Ltd10% OwnerMar 19, 2015 Sale$14.5046,141669,0454,595,187Mar 20, 2015, 02:37 PM
Novartis Bioventures Ltd10% OwnerMar 18, 2015 Sale$14.503,00043,5004,641,328Mar 20, 2015, 02:37 PM
Satter Muneer A10% OwnerSep 22, 2014 Buy$15.00150,0002,250,0001,771,688Sep 24, 2014, 05:54 PM
Apple Tree Partners II - Annex, L.P.DirectorSep 22, 2014 Buy$15.00237,5003,562,5003,568,438Sep 24, 2014, 05:52 PM
Harrison Seth LoringDirectorSep 22, 2014 Buy$15.00362,5005,437,5007,912,079Sep 24, 2014, 05:44 PM
Novartis Bioventures Ltd10% OwnerSep 22, 2014 Buy$15.00325,0004,875,0004,644,328Sep 24, 2014, 05:42 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Perrin StevenPresident11/23/20222,597
Gros David-Alexandre CChief Executive Officer12/20/20218,960
Gros David-Alexandre CChief Executive Officer08/17/202124,840
Gros David-Alexandre CChief Executive Officer06/09/202124,030
OrbiMed Israel GP Ltd.10% Owner12/02/20202,229,120
Logos Global Management LP10% Owner10/30/20202,341,714
Logos Global Management LP10% Owner10/30/2020345,559
TURKEL CATHERINE C.President05/21/20193,658
TURKEL CATHERINE C.President05/20/201914,953
Kuwahara JonSee Remarks05/21/20192,022
Kuwahara JonSee Remarks05/20/20198,274
FLESHER GREGORY J.Chief Executive Officer05/21/20195,614
FLESHER GREGORY J.Chief Executive Officer05/20/201922,953
OrbiMed Israel GP Ltd.Director05/02/20192,003,232
Chimovits ErezDirector05/02/20192,003,232
LIFESCI INDEX PARTNERS LLC10% Owner04/30/2019540
TURKEL CATHERINE C.President09/11/201877,671
TURKEL CATHERINE C.President09/12/201883,476
TURKEL CATHERINE C.President09/05/20183,193
FLESHER GREGORY J.Chief Executive Officer05/10/2017589,000
TURKEL CATHERINE C.Chief Development Officer05/10/2017110,999
OCAMPO CHRISTINESee Remarks05/10/2017100,000
Buckley Stephen Jr.Director03/15/201645,920
Morrison Jodie PopePresident and CEO01/08/201632,449
Buckley Stephen Jr.Director11/11/201533,750
McBride John S.Chief Operating Officer09/21/201556,565
McBride John S.Chief Operating Officer09/21/2015189,135
Kalowski LeeChief Financial Officer09/08/201561,291
Kalowski LeeChief Financial Officer09/02/201527,968
Morrison Jodie PopePresident and CEO07/29/20159,411
Morrison Jodie PopePresident and CEO07/28/201518,960
Morrison Jodie PopePresident and CEO07/29/20157,727
Morrison Jodie PopePresident and CEO07/28/2015164,400
Morrison Jodie Pope07/22/201510,624
Novartis Bioventures Ltd10% Owner07/15/201550,844
Novartis Bioventures Ltd10% Owner07/14/2015401,477
Novartis Bioventures Ltd10% Owner07/13/2015292,717
Morrison Jodie PopePresident and CEO06/29/201512,640
Morrison Jodie PopePresident and CEO06/26/201512,640
Morrison Jodie PopePresident and CEO06/29/2015109,600
Morrison Jodie PopePresident and CEO06/26/2015110,640
McBride John S.Chief Operating Officer06/24/20151,257
McBride John S.Chief Operating Officer06/23/201528,073
McBride John S.Chief Operating Officer06/22/20158,380
McBride John S.Chief Operating Officer06/23/201593,800
McBride John S.Chief Operating Officer06/22/201528,040
McBride John S.Chief Operating Officer06/24/20154,260
Novartis Bioventures Ltd10% Owner06/16/201515,982
Novartis Bioventures Ltd10% Owner06/15/2014209,833
Novartis Bioventures Ltd10% Owner06/12/201584,050
Novartis Bioventures Ltd10% Owner06/11/2015395,825
Kalowski LeeChief Financial Officer04/16/201559,371
Kalowski LeeChief Financial Officer04/02/201525,854
Novartis Bioventures Ltd10% Owner03/19/2015669,045
Novartis Bioventures Ltd10% Owner03/18/201543,500
Satter Muneer A10% Owner09/22/20142,250,000
Apple Tree Partners II - Annex, L.P.Director09/22/20143,562,500
Harrison Seth LoringDirector09/22/20145,437,500
Novartis Bioventures Ltd10% Owner09/22/20144,875,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR
STOCK BUYBACKS FOR
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-17.87%
1Q
12/31/2023
06/30/2023
2.55%
2Q
12/31/2023
09/30/2022
72.57%
5Q
12/31/2023
06/30/2022
72.57%
6Q
12/31/2023
03/31/2022
71.79%
7Q
12/31/2023
12/31/2021
66.17%
8Q
12/31/2023
09/30/2021
66.17%
9Q
12/31/2023
06/30/2021
66.17%
10Q
12/31/2023
03/31/2021
66.00%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-17.87%
1Q
06/30/2023
2.55%
2Q
09/30/2022
72.57%
5Q
06/30/2022
72.57%
6Q
03/31/2022
71.79%
7Q
12/31/2021
66.17%
8Q
09/30/2021
66.17%
9Q
06/30/2021
66.17%
10Q
03/31/2021
66.00%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...